Current position:Home >Product >
1-Pyrazolidinecarbothioamide,N-[4-chloro-3-(trifluoromethyl)phenyl]-3-oxo-4,5-diphenyl-, (4R,5S)-rel-
1-Pyrazolidinecarbothioamide,N-[4-chloro-3-(trifluoromethyl)phenyl]-3-oxo-4,5-diphenyl-, (4R,5S)-rel-(150351-93-2)
- Name: 1-Pyrazolidinecarbothioamide,N-[4-chloro-3-(trifluoromethyl)phenyl]-3-oxo-4,5-diphenyl-, (4R,5S)-rel-
- Synonyms:1-Pyrazolidinecarbothioamide,N-[4-chloro-3-(trifluoromethyl)phenyl]-3-oxo-4,5-diphenyl-, trans- (9CI);1-Pyrazolidinecarbothioamide,N-[4-chloro-3-(trifluoromethyl)phenyl]-3-oxo-4,5-diphenyl-, trans-(?à)-; LY 219057
- Molecular Formula:C23H17 Cl F3 N3 O S
- Molecular Weight:
- CAS Registry Number:150351-93-2
- EINECS:
- Melting Point:
- Water Solubility:
CAS No.150351-93-2 LY 219057
Assay:98% Appearance:Powder Package:inquiry Storage:Store in a cool and dry place and at 0 - 4 掳C for short term (days to weeks) or -20 掳C for long term (months to years). Transportation:inquiry Application:LY 219057, a phenylpyrazolidine derivative, has been found to be a CCK receptor antagonist that could probably be useful in gastrointestinal disorder studies.
Min. Order:0
Supplier:BOC Sciences [
United States]
Other Product
- 150693-43-9/11-OH PRADIMICIN T1
- 90802-19-0/1-propanone, 2-amino-3-mercapto-1-(sulfooxy)-, sodium salt (1:1)
- 4214-62-4/1-benzylpyrimidin-2(1H)-one
- 67026-84-0/2-(2-methylbutan-2-yl)-1-pyridin-3-yl-3-pyrimidin-2-ylguanidine
- 93777-84-5/4-[[[(3,4-dichlorophenyl)amino]carbonyl]amino]-N,N,N-trimethylanilinium methyl sulphate
- 90268-63-6/2-Butenedioic acid (Z)-, di-C10-20-branched and linear alkyl esters
- 93964-88-6/4-[(2-chloro-4-nitrophenyl)azo]-N-[2-(dodecyloxy)ethyl]-N-ethyl-aniline
- 42058-59-3/3-HYDROXYPHENYLACETIC ACID METHYL ESTER
- 82535-76-0/(2S,3R)-2,3-Dihydroxy-2-isopropylbutanoic acid [[(7R)-5,6,7,7aα-tetrahydro-7β-[(E)-2-methyl-2-butenoyloxy]-3H-pyrrolizin]-1-ylmethyl] ester
- 163597-24-8/Ergosta-8,24(28)-dien-26-oicacid, 4-methyl-3,11-dioxo-, (4a,5a,25S)-
- 68071-25-0/Methyl methacrylate, acrylonitrile, butadiene, itaconic acid polymer, methyl ester, ammonium salt
- 130289-38-2/Ethanone,1-[3-[4-(acetyloxy)-1-hydroxy-1,5-dimethyl-5-hexenyl]-2,3,3a,4,7,7a-hexahydro-7a-methyl-1H-inden-5-yl]-(9CI)
- 87540-32-7/4-[7-(pyrrolidin-1-yl)[1,2,4]triazolo[3,4-a]phthalazin-3-yl]benzoic acid
- 68966-72-3/Toluene diisocyanate, alpha-hydro-omega-hydroxypoly(oxy(methyl-1,2-ethanediyl)), ether with 2-ethyl-2-(hydroxymethyl)-1,3-propanediol (3:1), alpha-hydro-omega-hydroxypoly(oxy(methyl-1,2-ethanediyl)), 1,3-butylene glycol polymer
- 1072-82-8/3-ACETYLPYRROLE
- 7251-59-4/3-[(3E)-3-phenyl-3-(phenylhydrazono)propyl]-1H-indole
- 94136-01-3/5-(2-bromoethyl)quinolin-8-ol
- 3539-42-2/4,4'-ISOPROPYLIDENEDIPHENOXYACETIC ACID
- 6109-02-0/ethyl N-(2-ethylbutanoyl)glycinate
- 150351-93-2/1-Pyrazolidinecarbothioamide,N-[4-chloro-3-(trifluoromethyl)phenyl]-3-oxo-4,5-diphenyl-, (4R,5S)-rel-
- 71181-76-5/pentakis(2,2,2-trifluoroethoxy)-lambda~5~-phosphane
- 138930-07-1/protein 60K, Chlamydia trachomatis
- 16711-91-4/11-monoketofusidic acid
- 127654-02-8/(6E)-6-(6-methyl-5-oxo-5,6-dihydro-11H-pyrido[4,3-c][1]benzazepin-11-ylidene)hexanoic acid
- 3370-28-3/o-di-tert-pentylbenzene
- 74051-85-7/Propanoic acid, 3-(2-(2-(8-heptadecenyl)-4,5-dihydro-1H-imidazol-1-yl)ethoxy)-, potassium salt
- 13961-48-3/2,3-diphenylquinazoline-4(3H)-thione
- 16339-21-2/4-Methyl-4-(methylnitrosoamino)-2-pentanone
- 1332-10-1/potassium arsenite solution
- 80758-77-6/3-methylbutyl bicyclo[2.2.1]hept-5-ene-2-carboxylate